Matthew Hamilton Rosenberg’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-70
Closed -$384 891
2023
Q4
$384 Hold
70
﹤0.01% 832
2023
Q3
$365 Hold
70
﹤0.01% 835
2023
Q2
$809 Hold
70
﹤0.01% 804
2023
Q1
$874 Hold
70
﹤0.01% 840
2022
Q4
$1.38K Sell
70
-1
-1% -$22 ﹤0.01% 795
2022
Q3
$2K Buy
71
+1
+1% +$28 ﹤0.01% 769
2022
Q2
$2K Hold
70
﹤0.01% 750
2022
Q1
$2K Hold
70
﹤0.01% 711
2021
Q4
$2K Hold
70
﹤0.01% 690
2021
Q3
$3K Hold
70
﹤0.01% 651
2021
Q2
$5K Hold
70
﹤0.01% 551
2021
Q1
$4K Hold
70
﹤0.01% 532
2020
Q4
$3K Hold
70
﹤0.01% 522
2020
Q3
$2K Hold
70
﹤0.01% 515
2020
Q2
$2K Buy
+70
New +$2.95K ﹤0.01% 536

Other funds holding INGN

Matthew Hamilton Rosenberg's INGN Position: Q1 2024 in Review

Matthew Hamilton Rosenberg sold out of Inogen (INGN) in Q1 2024, closing a stake of 70 shares — an estimated $384 sold.

Matthew Hamilton Rosenberg first reported a position in INGN in Q2 2020 and held it in 15 quarters. The position peaked at $5K in Q2 2021. 129 funds tracked by Wall St. Rank hold INGN as of Q1 2024.

  • Matthew Hamilton Rosenberg reported no remaining Inogen position as of Q1 2024 after selling out during the quarter.
  • Matthew Hamilton Rosenberg sold 70 Inogen shares in Q1 2024, an estimated $384.
  • Matthew Hamilton Rosenberg first reported a position in Inogen in Q2 2020 and held it in 15 quarters.
  • Matthew Hamilton Rosenberg's Inogen position peaked at $5K in Q2 2021.
  • 129 funds tracked by Wall St. Rank held Inogen as of Q1 2024.

Based on Matthew Hamilton Rosenberg's 13F filing for Q1 2024, filed 22 Apr 2024.